<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus nuclear antigen (EBNA) preparations from three sources were tested with sera from <z:mpath ids='MPATH_458'>normal</z:mpath> individuals and patients with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and American and Chinese nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Individual sera with discordant antibody patterns were noted in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="2" pm="."><plain>Sera from both NPC groups gave significantly higher anti-EBNA titers on cell lines converted with P3HR-1 or B95-8 virus compared with anti-EBNA titers on Raji cells </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-EBNA titers of Chinese NPC sera showed no correlation among the three EBNA sources, while <z:hpo ids='HP_0000001'>all</z:hpo> other groups had highly correlated titers </plain></SENT>
<SENT sid="4" pm="."><plain>Cross-absorption experiments present evidence for more than one antigenic determinant on EBNA </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest an additional parameter for distinguishing Chinese NPC from other EBV-related disorders </plain></SENT>
</text></document>